Blood-brain barrier permeability for ammonia in patients with different grades of liver fibrosis is not different from healthy controls

Journal of Cerebral Blood Flow and Metabolism

Volumn 30, Issue 7, 2010, Pages 1384-1393

  Goldbecker, Annemarie ^a   Buchert, Ralph ^b   Berding, Georg ^a   Bokemeyer, Martin ^a   Lichtinghagen, Ralf ^a   Wilke, Florian ^b   Ahl, Björn ^a   Weissenborn, Karin ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

cerebral ammonia metabolism; cerebral blood flow; hepatic encephalopathy; matrix metalloproteinases; positron emission tomography

Indexed keywords

AMMONIA; AMMONIA N 13; GLUTAMINE; WATER O 15;

ADULT; ARTICLE; BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; BRAIN LEVEL; BRAIN METABOLISM; BRAIN PERFUSION; BRAIN TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LIVER CIRRHOSIS; LIVER FIBROSIS; MALE; MEMBRANE PERMEABILITY; MEMBRANE TRANSPORT; METABOLIC CLEARANCE RATE; METABOLIC RATE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

AGED; AMMONIA; BLOOD-BRAIN BARRIER; BRAIN; CAPILLARY PERMEABILITY; FEMALE; GLUTAMINE; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER CIRRHOSIS; MAGNETIC RESONANCE SPECTROSCOPY; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY;

EID: 77954242705     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1038/jcbfm.2010.22     Document Type: Article

References (30)

1. Ahl B, Weissenborn K, van den Hoff J, Fischer-Wasels D, Köstler H, Hecker H, Burchert W (2004) Regional differences in cerebral blood flow and cerebral ammonia metabolism in patients with cirrhosis. Hepatology 40:73-79
2. Andersson JLR, Vagnhammar BE, Schneider H (1995) Accurate attenuation correction despite movement during PET imaging. J Nucl Med 36:670-678
3. Berding G, Banati RB, Buchert R, Chierichetti F, Grover VPB, Kato A, Keiding S, Taylor-Robinson SD (2009) Radiotracer imaging studies in hepatic encephalopathy: ISHEN practice guidelines. Liver Int 29:621-628
4. Butterworth RF (2003) Pathogenesis of hepatic encephalo-pathy: new insights from neuroimaging and molecular studies. J Hepatol 39:278-285
5. Carroll TJ, Teneggi V, Jobin M, Squassante L, Treyer V, Hany TF, Burger C, Wang L, Bye A, von Schulthess GK, Buck A (2002) Absolute quantification of cerebral blood flow with magnetic resonance, reproducibility of the method, and comparison with H2(15)O positron emission tomography. J Cereb Blood Flow Metab 22:1149-1156
6. 13N labeled ammonia in rat brain. Journal Biol Chem 254:4982-4992
7. Gjedde A (1982) Calculation of cerebral glucose phosphor-ylation from brain uptake of glucose analogs in vivo: a re-examination. Brain Res 257:237-274
8. Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN, Holden J, Houle S, Huang SC, Ichise M, Iida H, Ito H, Kimura Y, Koeppe RA, Knudsen GM, Knuuti J, Lammertsma AA, Laruelle M, Logan J, Maguire RP, Mintun MA, Morris ED, Parsey R, Price JC, Slifstein M, Sossi V, Suhara T, Votaw JR, Wong DF, Carson RE (2007) Consensus nomenclature for in vivo imaging of rever-sibly binding radioligands. J Cereb Blood Flow Metab 27:1533-1539
9. Iversen P, Hansen DA, Bender D, Rodell A, Munk OL, Cumming P, Keiding S (2006) Peripheral benzodiaze-pine receptors in the brain of cirrhosis patients with manifest hepatic encephalopathy. Eur J Nucl Med Mol Imaging 33:810-816
10. Iversen P, Sørensen M, Bak LK, Waagepetersen HS, Vafaee MS, Borghammer P, Mouridsen K, Jensen SB, Vilstrup H, Schousboe A, Ott P, Gjedde A, Keiding S (2009) Low cerebral oxygen consumption and blood flow in patients with cirrhosis and an acute episode of hepatic encephalopathy. Gastroenterology 136:863-871
11. 13N-ammonia during acute hepatic encephalopathy in cirrhosis measured by positron emission tomography.
12. Hepatology 43:42-50. Erratum (2006) Hepatology 44:1056
13. Keiding S, Sørensen M, Munk OL, Bender D. Human 13N-ammonia PET studies: The importance of measuring 13N-ammonia metabolites in blood. Metab Brain Dis, accepted for publication
14. Köstler H (1998) Proton magnetic resonance spectroscopy in portal-systemic encephalopathy. Metab Brain Dis 13:291-301
15. Lockwood AH, Finn RD, Campbell JA, Richman TB (1980) Factors thataffect the uptake of ammonia by the rain: The blood-brain ph Gradient. Brain Res 181: 259-266
16. Lockwood AH, Bolomey L, Napoleon F (1984) Blood-brain barrier to ammonia in humans. J Cereb Blood Flow Metab 4:516-522
17. Lockwood AH, Yap EWH, Wong W-H (1991) Cerebral ammonia metabolism in patients with severe liver disease and minimal hepatic encephalopathy. J Cereb Blood Flow Metab 11:337-341
18. Lockwood AH, Wack DS (2006) The brain permeability-surface product for ammonia. Hepatology 44:1052-3; author reply 1053-1054
19. Lockwood AH (2007) Controversies in ammonia metabolism: implications for hepatic encephalopathy. Metab Brain Dis 22:285-289
20. Patlak CS, Blasberg RG, Fenstermacher JD (1983) Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 3:1-7
21. 3. Stroke 8:694-702
22. Phelps ME, Huang S-C, Hoffman EJ, Selin C, Kuhl DE (1981) Cerebral extraction of N-13 ammonia: Its depen dence on cerebral blood flow and capillary permeabil ity-surface area product. Stroke 12:607-619
23. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Will R (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60:646-649
24. Rosenspire KC, Schwaiger M, Mangner TJ, Hutchins GD, Sutorik A, Kuhl DE (1990) Metabolic fate of [13N]am-monia in human and canine blood. J Nucl Med 31:163-167
25. Schomerus H, Weissenborn K, Hamster W, Rueckert N, Hecker H (1999) PSE-Syndrom-Test. Psychodiagnos-tisches Verfahren zur quantitativen Erfassung der (minimalen) portosystemischen Enzephalopathie. Frankfurt: Swets Test Services
26. Sørensen M, Munk OL, Keiding S (2009) Backflux of ammonia from brain to blood in human subjects with and without hepatic encephalopathy. Metab Brain Dis 24:237-242
27. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, Mazoyer B, Joliot M (2002) Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 15:273-289
28. van den Hoff J, Burchert W, Börner AR, Fricke H, Kühnel G, Meyer GJ, Otto D, Weckesser E, Wolpers HG, Knapp WH (2001) [1-(11)C]Acetate asa quantitative perfusion tracer in myocardial PET. J Nucl Med 42:1174-1182
29. van den Hoff J, Burchert W, Müller-Schauenburg W, Meyer GJ, Hundeshagen H (1993) Accurate local blood flow measurements with dynamic PET: fast determination of input function delay and dispersion by multilinear minimization. J Nucl Med 34:1770-1777
30. Weissenborn K, Ahl B, Fischer-Wasels D, van den Hoff J, Hecker H, Burchert W, Köstler H (2007) Correlations between MRS alterations and cerebral ammonia and glucose metabolism in cirrhotic patients with and without hepatic encephalopathy. GUT 56:1736-1742